We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pneumatic Sleeves and Congestive Heart Failure (Sleeves-Bickel)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01691417
First Posted: September 24, 2012
Last Update Posted: September 24, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Western Galilee Hospital-Nahariya
  Purpose
Based on the reversal of the adverse cardiovascular parameters during Laproscopic Surgery and its influence on cardiac activity in healthy subjects, the investigators expect to improved cardiac function in patients suffering from congestive heart failure.

Condition Intervention
Congestive Heart Failure Device: Intermittent Sequntial Pnumatic Compression Leg Sleeves

Study Type: Interventional
Official Title: The Impact of Intermittent Sequential Pneumatic Compression (ISPC) Leg Sleeves on Cardiac Performance in Patients With Congestive Heart Failure

Resource links provided by NLM:


Further study details as provided by Western Galilee Hospital-Nahariya:

Primary Outcome Measures:
  • Cardiac Output

Secondary Outcome Measures:
  • Systemic vascular resistance

Other Outcome Measures:
  • Stroke volume

Arms Assigned Interventions
Experimental: Pneumatic Sleeves Device: Intermittent Sequntial Pnumatic Compression Leg Sleeves
Experimental: Congestive Heart Failure Patients Device: Intermittent Sequntial Pnumatic Compression Leg Sleeves

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • CHF (as clinically evaluated and asessed by TTE)
  • Gave informed consent
  • NYHA Class II-III
  • LVEF equal or less than 40%

Exclusion Criteria:

  • Patients who could not sign informed consent
  • NYHA Class IV
  • Oxygen saturation less than 90% under room air
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01691417


Locations
Israel
Western Galilee Hospital
Nahariya, Israel, 22100
Sponsors and Collaborators
Western Galilee Hospital-Nahariya
  More Information

Responsible Party: Western Galilee Hospital-Nahariya
ClinicalTrials.gov Identifier: NCT01691417     History of Changes
Other Study ID Numbers: Sleeves-Bickel
First Submitted: September 9, 2012
First Posted: September 24, 2012
Last Update Posted: September 24, 2012
Last Verified: September 2012

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases